POET Technologies Inc. (POET) financials
NASDAQ · Technology · Semiconductors · 80 employees · CEO Suresh Venkatesan
- Price
- $5.20 -8.13%
- Market cap
- $686M
- Enterprise value
- $262M
- Last report
- Q2 '26 filed 2026-08-13
- Next report
- 2026-11-16
Valuation & key figures
- Market cap
- $686M EV $262M
- Revenue
- $1.71M Trailing 12 months
- Revenue growth
- +490% FY2026 consensus
- Profit margin
- -4,420.7% Net income / revenue, TTM
- P/E
- -7.3× Forward -20.8× (FY2026)
- P/S
- 400.8× Price / sales, TTM
- EV / EBITDA
- -3.2× TTM
- Free cash flow
- -$40.4M Trailing 12 months
- Net income
- -$75.7M Trailing 12 months
- Revenue estimate
- $6.35M FY2026 consensus
- Earnings
- 2026-11-16
- Dividend
- – No dividend
Key takeaways
Computed from the reported numbers - every statement carries the figure it rests on.
- Last report (2026-08-13): revenue beat by 14.0%, EPS in lineRevenue $570K vs $500K expected (+14.0%); EPS -$0.07 vs -$0.07 (0.0%).
- Revenue growth slowing: 112.3% year on yearQ2 '26 revenue $570K, against an average of 3,091.9% over the four quarters before.
- Operating margin -3,340.8% (TTM), +4,455.3 pp on a year agoOperating income grew -56.9% while revenue grew 266.1%.
- Capex 294.5% of revenue (a year ago 1,634.2%)$5.04M invested in the last 4 quarters (-34.0% on a year earlier). Free cash flow -$40.4M.
- Diluted share count up 100.3% in a year162M diluted shares in Q2 '26, 81.1M a year earlier.
- Net cash $789MCash + short-term investments $796M, debt incl. leases $7.8M; a year ago net cash $65.7M.
Last quarter: Q2 '26
Quarter ended 2026-06-30. Compared with the same quarter a year earlier and with the analyst consensus before the report.
Quarter vs a year ago
| Q2 '26 | Year ago | Change | |
|---|---|---|---|
| Revenue | $570K | $268K | +112.3% |
| Gross margin | -80.2% | 100.0% | -180.2 pp |
| Operating income | -$20.2M | -$8.76M | -130.6% |
| Operating margin | -3,542.7% | -3,261.9% | -280.8 pp |
| Net income | -$11.3M | -$17.3M | +34.3% |
| Diluted EPS | -$0.07 | -$0.21 | +66.8% |
| Operating cash flow | -$12.2M | -$7.74M | -57.3% |
| Capex | $2.98M | $2.11M | +41.3% |
| Free cash flow | -$15.2M | -$9.85M | -53.9% |
| R&D | $6.99M | $3.75M | +86.4% |
| Stock-based compensation | $0 | $1.17M | -100.0% |
Reported vs consensus
2026-08-13| Actual | Consensus | vs consensus | |
|---|---|---|---|
| Revenue | $570K | $500K | +14.0% |
| EPS (as estimated) | -$0.07 | -$0.07 | 0.0% |
From the report of 2026-08-13 for Q2 '26: revenue and the EPS analysts estimate (often adjusted), so it can differ from the EPS of the statements above.
EPS vs consensus
last 8 reportsRevenue
Where the money comes from - by business line and by region, quarter by quarter.
Revenue, operating income and growth
quarterlyMargins & cost structure
How much of each unit of revenue is left at each level - and where the costs go.
Margins
quarterlyCosts as % of revenue
quarterlyCash flow & capital allocation
Cash generated, what it is spent on, and what reaches shareholders.
Operating cash flow, capex, free cash flow
quarterlyUses of cash vs operating cash flow
fiscal yearsLast 4 quarters
cash flow statement- Operating cash flow
- -$35.3M
- Capex
- -$5.04M
- Buybacks
- $0
- Dividends
- $0
- Acquisitions
- $0
- Net debt issued
- -$1.03M
- Stock-based compensation
- $2.24M
- Free cash flow
- -$40.4M
- Returned to shareholders / FCF
- 0.0%
Share count and EPS
quarterly, dilutedBalance sheet
Liquidity, investments and debt at each quarter end.
Cash, investments and debt
quarter endsValuation & returns
Today's multiples against the company's own last five fiscal years; analyst targets and ratings.
Multiples and returns
TTM vs 5 fiscal years| Now | 5y average | Where today sits in the 5-year range | |
|---|---|---|---|
| P/E (TTM) | -7.3× | – | – |
| EV / EBITDA | -3.2× | – | – |
| EV / Sales | 152.8× | 1,962.5× | 75.2× – 7,931.3× |
| Price / FCF | -17.0× | – | – |
| Price / Book | 1.0× | 9.5× | 3.2× – 17.3× |
| FCF yield | -5.9% | -15.5% | -44.4% – -5.0% |
| Return on invested capital | -6.7% | -145.5% | -372.8% – -17.7% |
| Return on equity | -19.6% | -193.2% | -411.0% – -34.3% |
Analysts
Consensus target $5.75 (+10.6%)
range $3.50 – $8.00 · rating Buy
Outlook
Analyst consensus for the coming fiscal years and what it implies at today's price.
Consensus estimates
| Fiscal year | Revenue | Growth | EPS | Growth | P/E at today's price | Analysts (EPS) |
|---|---|---|---|---|---|---|
| FY2026 | $6.35M | +490.5% | -$0.25 | +63.2% | -20.8× | 1 |
| FY2027 | $82M | +1,192.0% | -$0.18 | +30.0% | -29.7× | 1 |
| FY2028 | $200M | +143.9% | $0.02 | +111.4% | 260.0× | 1 |
| FY2029 | $405M | +102.5% | $0.42 | +2,000.0% | 12.4× | 1 |
| FY2030 | $600M | +48.1% | $0.68 | +61.9% | 7.6× | 1 |
Financial statements
Every line of the income statement, balance sheet and cash flow statement - 12 quarters and 10 fiscal years, as values, as % of revenue or as growth.
Sources
Statements, segment revenue, metrics and estimates are standardised from the company's filings.
Data as of 2026-11-02